Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)
Clinical trial NCT00971425 · COMPLETED
Trial details
- NCT number
- NCT00971425
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-08
- Primary completion
- 2009-11-16
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.